Survival analyses of patients with thoracic complications secondary to bronchial carcinoma at the time of diagnosis

Respiration

Volumn 72, Issue 4, 2005, Pages 388-394

  Bülbül, Yilmaz ^a   Oztuna, Funda ^a   Topbaş, Murat ^a   Ozlu, Tevfik ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Atelectasis; Lung cancer; Pleural effusion; Prognosis; Survival; Thoracic complication

Indexed keywords

ADULT; AGED; ARTICLE; ATELECTASIS; CALCULATION; CONTROLLED STUDY; FEMALE; HUMAN; KAPLAN MEIER METHOD; LARYNGEAL NERVE; LUNG CARCINOMA; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; PLEURA EFFUSION; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; STATISTICAL SIGNIFICANCE; SUPERIOR CAVA VEIN SYNDROME; SURVIVAL;

AGED; ATELECTASIS; BRONCHIAL NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 23844488923     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086253     Document Type: Article

References (22)

1. Byrd RB, Carr DT, Miller WE, Payne WS, Woolner LB: Radiographic abnormalities in carcinoma of the lung as related to histological cell type. Thorax 1969;24:573-575.
2. Margolis ML: Non-small cell lung cancer - Clinical aspects, diagnosis, staging, and natural history; in Fishman AP (ed): Fishmans' Pulmonary Diseases and Disorders. New York, McGraw-Hill, 1998, vol 2, pp 1759-1781.
3. Brundage MD, Davies D, Mackillop WJ: Prognostic factors in non-small cell lung cancer: A decade of progress. Chest 2002;122:1037-1057.
4. Yip D, Harper PG: Predictive and prognostic factors in small cell lung cancer: Current status. Lung Cancer 2000;28:173-185.
5. Naito T, Satoh H, Iskikawa H, Yamashita YT, Kamma H, Takahashi H, Ohtsuka M, Hasegawa S: Pleural effusion as a significant prognostic factor in non-small cell lung cancer. Anticancer Res 1997;17:4743-4746.
6. Sugiura S, Ando Y, Minami H, Ando M, Sakai S, Shimokata K: Prognostic value of pleural effusion in patients with non-small cell lung cancer. Clin Cancer Res 1997;3:47-50.
7. Coen V, Van Lancker M, De Neve W, Storme G: Prognostic factors in locoregional non-small cell lung cancer treated with radiotherapy. Am J Clin Oncol 1995;18:111-117.
8. Martins SJ, Pereira JR: Clinical factors and prognosis in non-small cell lung cancer. Am J Clin Oncol 1999;22:453-457.
9. Würschmidt F, Bunemann H, Heilmann HP: Small cell lung cancer with and without superior vena cava syndrome: A multivariate analysis of prognostic factors in 408 cases. Int J Radiat Oncol Biol Phys 1995;33:77-82.
10. Mountain CF: Revisions in the international system for staging lung cancer. Chest 1997;111:1710-1717.
11. Manac'h D, Riquet M, Medioni J, Le Pimpec-Barthes F, Dujon A, Danel C: Visceral pleura invasion by non-small cell lung cancer: An underrated bad prognostic factor. Ann Thorac Surg 2001;71:1088-1093.
12. Aoe K, Hiraki A, Ueoka H, Kiura K, Tabata M, Tanaka M, Tanimoto M: Thrombocytosis as a useful prognostic indicator in patients with lung cancer. Respiration 2004;71:170-173.
13. Lopez-Encuentra A, Gomez De La Camara A, Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery: Validation of a central review board of staging prior to surgery for non-small-cell lung cancer - Impact on prognosis: A multicenter study. Respiration 2002;69:16-24.
14. Vaaler AK, Forrester JM, Lesar M, Edison M, Venzon D, Johnson BE: Obstructive atelectasis in patients with small cell lung cancer. Incidence and response to treatment. Chest 1997;111:115-120.
15. Beckles MA, Spiro SG, Colice GL, Rudd RM: Initial evaluation of the patient with lung cancer: Symptoms, signs, laboratory tests, and paraneoplastic syndromes. Chest 2003;123:97S-104S.
16. Tokics L, Hedenstierna G, Svensson L, Brismar B, Cederlund T, Lundquist H, Strandberg A: V/Q distribution and correlation to atelectasis in anesthetized paralyzed humans. J Appl Physiol 1996;81:1822-1833.
17. Dazzi C, Cariello A, Maioli P, Solaini L, Scarpi E, Rosti G, Lanzanova G, Marangolo M: Prognostic and predictive value of intratumoral microvessels density in operable non-small-cell lung cancer. Lung Cancer 1999;24:81-88.
18. Pujol JL, Quantin X, Jacot W, Boher JM, Grenier J, Lamy PJ: Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer. Lung Cancer 2003;39:131-138.
19. Hatzakis KD, Froudarakis ME, Bouros D, Tzanakis N, Karkavitsas N, Siafakas NM: Prognostic value of serum tumor markers in patients with lung cancer. Respiration 2002;69:25-29.
20. Maeda T, Ueoka H, Tabata M, Kiura K, Shibayama T, Gemba K, Takigawa N, Hiraki A, Katayama H, Harada M: Prognostic factors in advanced non-small cell lung cancer: Elevated serum levels of neuron specific enolase indicate poor prognosis. Jpn J Clin Oncol 2000;30:534-541.
21. Deslauriers J, Brisson J, Cartier R, Fournier M, Gagnon D, Piraux M, Beaulieu M: Carcinoma of the lung. Evaluation of satellite nodules as a factor influencing prognosis after resection. J Thorac Cardiovasc Surg 1989;97:504-512.
22. Yoshino I, Nakanishi R, Osaki T, Hasuda S, Taga S, Takenoyama M, Yoshimatsu T, Yasumoto K: Postoperative prognosis in patients with non-small cell lung cancer with synchronous ipsilateral intrapulmonary metastasis. Ann Thorac Surg 1997;64:809-813.